FindTrial
Sign In

To find out type of Raktadushti in Liver and bile diseased patient in relation with blood test.

An Observational Study To Evaluate The Type Of Raktdushti In Hepatobiliary Diseases In Relation With Hemogram. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/04/085296
Enrollment
100
Registered
2025-04-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K769- Liver disease, unspecified

Interventions

None listed

Sponsors

Dr Sagar Sanjay Solunke
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patient of age group 20-70 years irrespective of caste, gender, religion, habitat, occupation and socio-economic status willing to sign the consent. b) Known cases of Hepatobiliary diseases such as Hepatomegaly, Jaundice, Portal hypertension, Ascities, Liver cirrhosis, Viral hepatitis, Alcoholic liver diseases, Non alcoholic liver disease, Cholelithiasis.

Exclusion criteria

Exclusion criteria: a) Immuno-compromised Patients. b) Congenital Heart Disease c) Juvenile Diabetes d) Leukemia e) CA of Liver and Spleen. f) Hepatic encephalopathy g) Liver abscess h) Benign tumors of liver, gall bladder and bile duct

Design outcomes

Primary

MeasureTime frame
Severity of Raktadushti in Hepatobiliary diseases will be known at the end of the study.Timepoint: 1 Year 6 Month—

Secondary

MeasureTime frame
Hematological abnormalities will be known based on etiological factorsTimepoint: 1 Year 6 Month—

Countries

India

Contacts

Public ContactDr Hrishita Sandeep Dahilekar

Parul Institute of Ayurved and Research Vadodara, Gujrat

pandithrishita@gmail.com9420090602

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026